Dycom Industries Investing Cash Flow increased by 95.2% to -$80.36M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.1%, from -$68.60M to -$80.36M. Over 4 years (FY 2022 to FY 2026), Investing Cash Flow shows a downward trend with a 86.5% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$28.59M | -$35.53M | -$44.13M | -$43.43M | -$33.03M | -$39.07M | -$49.19M | -$62.64M | -$33.61M | -$39.96M | -$179.94M | -$52.65M | -$42.23M | -$76.73M | -$216.48M | -$59.77M | -$68.60M | -$39.09M | -$47.59M | -$1.68B | -$80.36M |
| QoQ Change | — | -24.3% | -24.2% | +1.6% | +23.9% | -18.3% | -25.9% | -27.3% | +46.3% | -18.9% | -350.3% | +70.7% | +19.8% | -81.7% | -182.1% | +72.4% | -14.8% | +43.0% | -21.7% | <-999% | +95.2% |
| YoY Change | — | — | — | — | -15.6% | -10.0% | -11.5% | -44.2% | -1.7% | -2.3% | -265.8% | +15.9% | -25.6% | -92.0% | -20.3% | -13.5% | -62.5% | +49.0% | +78.0% | <-999% | -17.1% |